POSEIDA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.645 USD | -2.40% |
|
-7.84% | -21.28% |
| May. 02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
| May. 01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Neutral |
| Resistance | 3.070 | 4.130 | 4.130 |
| Spread/Res. | -13.84% | -35.96% | -35.96% |
| Spread/Supp. | +32.25% | +32.25% | +62.27% |
| Support | 2.000 | 2.000 | 1.630 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- PSTX Stock
- Charts Poseida Therapeutics, Inc.